This alteration frequency increased to 40–50% in cohorts of metastatic samples and castration-resistant PCa (CRPC) tumors, again mostly through CNA of PTEN. These results are consistent with previous reports linking PTEN loss to PCa aggressiveness as it is increased in more aggressive disease settings (25–28). The gene discussed is PTEN; the disease is posterior cortical atrophy.